The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and immune suppression by reducing oxidative stress
- 1 May 2012
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 52 (9), 1560-1568
- https://doi.org/10.1016/j.freeradbiomed.2012.02.007
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology, 2011
- Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivoCellular Immunology, 2010
- Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimeticBiomedicine & Pharmacotherapy, 2010
- Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicityBiomedicine & Pharmacotherapy, 2010
- Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cellsFree Radical Biology & Medicine, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Pharmacology of a mimetic of glutathione disulfide, NOV-002Biomedicine & Pharmacotherapy, 2009
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: Modulation by ERK, ROS, glutathione, and thioredoxinFree Radical Biology & Medicine, 2007